Strong ubiquitous micro-promoters for recombinant adeno-associated viral vectors

Significant progress has been made in developing recombinant adeno-associated virus (rAAV) for clinical gene therapy. While rAAV is a versatile gene delivery platform, its packaging limit of 4.7 kb limits the diseases it can target. Here, we report two unusually small promoters that enable the expre...

Descripción completa

Detalles Bibliográficos
Autores principales: Chai, Sunghee, Wakefield, Leslie, Norgard, Mason, Li, Bin, Enicks, David, Marks, Daniel L., Grompe, Markus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10241652/
https://www.ncbi.nlm.nih.gov/pubmed/37287749
http://dx.doi.org/10.1016/j.omtm.2023.05.013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10241652/
https://www.ncbi.nlm.nih.gov/pubmed/37287749
http://dx.doi.org/10.1016/j.omtm.2023.05.013

Ejemplares similares